Cereno Scientific AB Statistics

Total Valuation

STO:CRNO.B has a market cap or net worth of SEK 2.44 billion. The enterprise value is 2.55 billion.

Market Cap	2.44B
Enterprise Value	2.55B

Important Dates

The last earnings date was Thursday, November 27, 2025.

Earnings Date	Nov 27, 2025
Ex-Dividend Date	n/a

Share Statistics

STO:CRNO.B has 295.32 million shares outstanding. The number of shares has decreased by -4.55% in one year.

Current Share Class	294.59M
Shares Outstanding	295.32M
Shares Change (YoY)	-4.55%
Shares Change (QoQ)	+0.49%
Owned by Insiders (%)	9.75%
Owned by Institutions (%)	23.41%
Float	249.41M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	52.28
PB Ratio	12.57
P/TBV Ratio	13.53
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-22.47
EV / Sales	54.56
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-21.45

Financial Position

The company has a current ratio of 4.34, with a Debt / Equity ratio of 0.93.

Current Ratio	4.34
Quick Ratio	4.25
Debt / Equity	0.93
Debt / EBITDA	n/a
Debt / FCF	-1.52
Interest Coverage	-1.78

Financial Efficiency

Return on equity (ROE) is -53.34% and return on invested capital (ROIC) is -13.07%.

Return on Equity (ROE)	-53.34%
Return on Assets (ROA)	-12.33%
Return on Invested Capital (ROIC)	-13.07%
Return on Capital Employed (ROCE)	-19.43%
Revenue Per Employee	4.67M
Profits Per Employee	-11.33M
Employee Count	10
Asset Turnover	0.13
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +31.80% in the last 52 weeks. The beta is -0.04, so STO:CRNO.B's price volatility has been lower than the market average.

Beta (5Y)	-0.04
52-Week Price Change	+31.80%
50-Day Moving Average	7.81
200-Day Moving Average	8.27
Relative Strength Index (RSI)	57.70
Average Volume (20 Days)	800,627

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, STO:CRNO.B had revenue of SEK 46.66 million and -113.29 million in losses. Loss per share was -0.39.

Revenue	46.66M
Gross Profit	46.66M
Operating Income	-72.76M
Pretax Income	-113.29M
Net Income	-113.29M
EBITDA	-71.97M
EBIT	-72.76M
Loss Per Share	-0.39

Full Income Statement

Balance Sheet

The company has 74.18 million in cash and 180.40 million in debt, giving a net cash position of -106.22 million or -0.36 per share.

Cash & Cash Equivalents	74.18M
Total Debt	180.40M
Net Cash	-106.22M
Net Cash Per Share	-0.36
Equity (Book Value)	194.09M
Book Value Per Share	0.66
Working Capital	59.68M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -115.99 million and capital expenditures -2.67 million, giving a free cash flow of -118.66 million.

Operating Cash Flow	-115.99M
Capital Expenditures	-2.67M
Free Cash Flow	-118.66M
FCF Per Share	-0.40

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -155.94% and -242.82%.

Gross Margin	100.00%
Operating Margin	-155.94%
Pretax Margin	-242.82%
Profit Margin	-242.82%
EBITDA Margin	-154.26%
EBIT Margin	-155.94%
FCF Margin	n/a

Dividends & Yields

STO:CRNO.B does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	4.55%
Shareholder Yield	4.55%
Earnings Yield	-4.64%
FCF Yield	-4.86%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

STO:CRNO.B has an Altman Z-Score of 5.41 and a Piotroski F-Score of 1.

Altman Z-Score	5.41
Piotroski F-Score	1